Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation-Reference-Cited by-同舟云学术

Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation

Published:2015 Issue: Volume:2 Page:14057
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Saydaminova Kamola,Ye Xun,Wang Hongjie,Richter Maximilian,Ho Martin,Chen HongZhuan,Xu Ning,Kim Jin-Soo,Papapetrou Eirini,Holmes Michael C,Gregory Philip D,Palmer Donna,Ng Philip,Ehrhardt Anja,Lieber André

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference49 articles.

1. A guide to genome engineering with programmable nucleases;Kim;Nat Rev Genet,2014

2. Targeted genome editing in human repopulating haematopoietic stem cells;Genovese;Nature,2014

3. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo;Holt;Nat Biotechnol,2010

4. Lentiviral vectors encoding zinc-finger nucleases specific for the model target locus HPRT1;Pelascini;Methods Mol Biol,2014

5. Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zinc-finger nucleases;Pelascini;Hum Gene Ther Methods,2013

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug delivery systems for CRISPR-based genome editors;Nature Reviews Drug Discovery;2023-09-18

2. In vivo HSC prime editing rescues Sickle Cell Disease in a mouse model;Blood;2023-02-17

3. In vivo editing of the pan-endothelium by immunity evading simian adenoviral vector;Biomedicine & Pharmacotherapy;2023-02

4. In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations;Genes;2022-11-27

5. In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies;JCI Insight;2022-10-10